RecruitingPhase 3NCT07000357

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Studying Holt-Oram syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
AstraZeneca
Intervention
AZD0780(drug)
Enrollment
15100 target
Eligibility
18 years · All sexes
Timeline
2025 – 2029

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07000357 on ClinicalTrials.gov

Other trials for Holt-Oram syndrome

Additional recruiting or active studies for the same condition.

See all trials for Holt-Oram syndrome →

← Back to all trials